Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sherene Loi
Based on 93 articles published since 2007
||||
Expertise Level
The expertise of Sherene Loi ranks in the
  • Top 0.02%
  • ... of 254,621 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 93 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Loi, S   ·   Loi, Sherene
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2017
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: · Pubmed 28668293
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Pubmed 28534250
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • German Breast Group GBG Forschungs GmbH, Neu-Isenburg, Germany · Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · National Cancer Center, Goyang-si, South Korea. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Breast Oncology, NHO Osaka National Hospital, Osaka-city, Japan. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Institut Gustave Roussy, Villejuif, France. · Brustzentrum der Universität München (LMU), Munich, Germany. · University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pfizer Oncology, Cambridge, Massachussets, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pubmed 28652278
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Immunology, Monash University, Clayton, Victoria, Australia. · Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia. · St. Vincent's Hospital, University of New South Wales, Darlinghurst, Sydney, Australia. · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Pubmed 28848054
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 26755511
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia. · Write Source Medical Pty Ltd, Sydney, New South Wales, Australia. · Deakin University, Warun Ponds, Victoria, Australia. · Mater Health Services/Mater Research Institute, South Brisbane, Queensland, Australia. · Wesley Medical Centre and University of Queensland, Queensland, Australia. · Royal Melbourne Hospital, Parkville, Victoria, Australia. · Peter MacCallum Cancer Centre, Victoria, Australia. · Fiona Stanley Hospital, Perth, Western Australia, Australia. · Pubmed 27001208
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Department of Obstetrics and Gynecology, Brustzentrum der Universität München, München (LMU), Germany · Pfizer Inc, New York, USA. · Department of Molecular Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, National Cancer Center, Goyang-si, Korea. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Transfusion, Aichi Cancer Center Hospital, Nagoya, Japan. · Pfizer Inc, Cambridge, USA. · Department of Oncology, German Breast Group Forschungs GmbH, Neu-Isenburg, Germany. · Pubmed 27029704
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine. · National Cancer Center, Goyang-si, South Korea. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · NHO Osaka National Hospital, Osaka, Japan. · Istituto Europeo di Oncologia, Milan, Italy. · Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München (LMU), Munich, Germany. · Pfizer, San Diego, CA, USA. · Pfizer, Cambridge, MA, USA. · Pfizer, Collegeville, PA, USA. · Pfizer, New York, NY, USA. · University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 26947331
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Department of Oncology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Surgery, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Humanitas University, Rozzano-Milan, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Immunology and Inflammation, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Pubmed 27912781
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium, (DKTK), Berlin, Germany. · Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. · Department of Pathology, Center for Integrated Diagnostics (CID), Massachusetts General Hospital, Boston, MA, USA. · Hämatoonkologische Schwerpunktpraxis, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital Schleswig-Hostein, Kiel, Germany. · Praxisklinik Krebsheilkunde für Frauen/Brustzentrum, Berlin, Germany. · Department of Gynecology and Obstetrics, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institute of Pathology, Technical University Munich, Munich, Germany. · Center for Hematology and Oncology Bethanien, Frankfurt/Main, Germany. · Breast Unit, Kliniken Essen Mitte, Essen, Germany. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · German Breast Group c/o (GBG Forschungs GmbH), Neu-Isenburg, Germany. · Pubmed 27611952
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Lautenberg Centre, Hebrew University, Jerusalem, Israel. · Division of Medical Genetics, Department of Pediatrics and Neurobiology, Duke University, Durham, North Carolina. · Division of Cell Biology and Molecular Medicine, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia. · Pubmed 27231202
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Department of Oncology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Pathology, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Department of Oncology, Regional Oncology Center, 66a Katowicka St, 45-060, Opole, Poland. · Department of Neurosurgery, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Medical University of Lublin, 1 Al. Racławickie, 20-059, Lublin, Poland. · Department of Oncology, Regional Oncology Center, 12 Ogrodowa St, 15-027, Białystok, Poland. · Department of Pathology, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Regional Hospital, 18 Żołnierska St, 10-561, Olsztyn, Poland. · Department of Oncology, Regional Oncology Center, 62 Pabianicka St, 93-513, Łódź, Poland. · Department of Pathology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, VIC, 8006, Australia. · Pubmed 27117582
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia · Pubmed 26487579
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 26255199
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia · Pubmed 25753442
2014
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2013
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. · Pubmed 23776241
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
2010
  • Department of Research, Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia. · Pubmed 20479250
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2015
  • From Royal Marsden Hospital, London (N.C.T.); National Cancer Center, Goyang-si, South Korea (J.R.); Institut Gustave Roussy, Villejuif, France (F.A.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Sunnybrook Odette Cancer Centre, Toronto (S.V.); Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany; Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.); and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2014
  • Translational Breast Cancer Genomics Laboratory, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25290412
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25188474
  • Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 22820642
Probable:    University of Melbourne      
2017
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: · Pubmed 28668293
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Pubmed 28534250
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Immunology, Monash University, Clayton, Victoria, Australia. · Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia. · St. Vincent's Hospital, University of New South Wales, Darlinghurst, Sydney, Australia. · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Pubmed 28848054
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
  • Peter MacCallum Cancer Centre, Melbourne. · Latrobe Regional Hospital, Traralgon. · University of Melbourne, Melbourne, Australia. · Pubmed 28430863
2016
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia · Pubmed 25753442
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY. · Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research; Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital; Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK; Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA; Fabrice Andre, Institut Gustave Roussy, Villejuif, France; Sherene Loi, University of Melbourne, Melbourne, Australia; Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany; and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY. · Pubmed 27269946
2015
  • From Royal Marsden Hospital, London (N.C.T.); National Cancer Center, Goyang-si, South Korea (J.R.); Institut Gustave Roussy, Villejuif, France (F.A.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Sunnybrook Odette Cancer Centre, Toronto (S.V.); Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany; Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.); and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
2012
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 22820642
2010
  • Department of Computer Science and Software Engineering, The University of Melbourne, Parkville 3010, VIC, Australia. · Pubmed 20500821
Probable:    Vanderbilt University   Contact    
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
2016
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 93 total) written by Sherene Loi about Breast Neoplasms:

  • Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice. 2017
  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. 2017
  • Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC). 2017
  • Advancing Immunotherapy in Metastatic Breast Cancer. 2017
  • Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). 2017
  • Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results. 2017
  • Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer. 2017
  • Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. 2017
  • Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer. 2017
  • Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Sherene Loi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
Vanderbilt University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2017
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: · Pubmed 28668293
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Pubmed 28534250
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • German Breast Group GBG Forschungs GmbH, Neu-Isenburg, Germany · Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · National Cancer Center, Goyang-si, South Korea. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Breast Oncology, NHO Osaka National Hospital, Osaka-city, Japan. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Institut Gustave Roussy, Villejuif, France. · Brustzentrum der Universität München (LMU), Munich, Germany. · University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pfizer Oncology, Cambridge, Massachussets, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pubmed 28652278
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Immunology, Monash University, Clayton, Victoria, Australia. · Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia. · St. Vincent's Hospital, University of New South Wales, Darlinghurst, Sydney, Australia. · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Pubmed 28848054
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Department of Pathology, European Institute of Oncology, Milan. · School of Medicine, University of Milan, Milan. · Cancer Prevention and Genetics, European Institute of Oncology, Milan. · Epidemiology and Biostatistics, European Institute of Oncology, Milan. · Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan. · Division of Medical Oncology, E.O. Ospedali Galliera, Genoa. · Experimental Therapeutics European Institute of Oncology, Milan. · Division of Senology, European Institute of Oncology, Milan, Italy. · Department of Pathology, GZA, Breast Cancer Translational Research Group, Jules Bordet Institute, Brussels. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre University of Melbourne, East Melbourne, Victoria, Australia. · Institute of Pathology Charité University Hospital, Berlin, Germany and German Cancer Consortium, Berlin, Germany. · Pubmed 28426105
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Department of Breast Medical Oncology, Yale University, Yale Cancer Center, New Haven, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science, Inverness, Scotland. · Breast Center, Department of Obstetrics and Gynecology, University of Munich, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Hospital Moinhos de Vento, Porto Alegre, Brazil. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · The Christie/NIHR Clinical Research Facility, Manchester, UK. · Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · Novartis, Cambridge. · Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, USA. · Pubmed 28177460
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 26755511
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia. · Write Source Medical Pty Ltd, Sydney, New South Wales, Australia. · Deakin University, Warun Ponds, Victoria, Australia. · Mater Health Services/Mater Research Institute, South Brisbane, Queensland, Australia. · Wesley Medical Centre and University of Queensland, Queensland, Australia. · Royal Melbourne Hospital, Parkville, Victoria, Australia. · Peter MacCallum Cancer Centre, Victoria, Australia. · Fiona Stanley Hospital, Perth, Western Australia, Australia. · Pubmed 27001208
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Department of Obstetrics and Gynecology, Brustzentrum der Universität München, München (LMU), Germany · Pfizer Inc, New York, USA. · Department of Molecular Oncology, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA. · Department of Medicine, National Cancer Center, Goyang-si, Korea. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Department of Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Medicine, Sunnybrook Odette Cancer Centre, Toronto, Canada. · Department of Transfusion, Aichi Cancer Center Hospital, Nagoya, Japan. · Pfizer Inc, Cambridge, USA. · Department of Oncology, German Breast Group Forschungs GmbH, Neu-Isenburg, Germany. · Pubmed 27029704
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine. · National Cancer Center, Goyang-si, South Korea. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · NHO Osaka National Hospital, Osaka, Japan. · Istituto Europeo di Oncologia, Milan, Italy. · Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München (LMU), Munich, Germany. · Pfizer, San Diego, CA, USA. · Pfizer, Cambridge, MA, USA. · Pfizer, Collegeville, PA, USA. · Pfizer, New York, NY, USA. · University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 26947331
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Department of Oncology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Surgery, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Humanitas University, Rozzano-Milan, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Immunology and Inflammation, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Pubmed 27912781
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium. · Oncology Biomarker Development, Genentech Inc., South San Francisco, CA, USA. · Department of Biostatistics, Genentech Inc., South San Francisco, CA, USA. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Department of Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France INSERM U1018, CESP, University of Paris, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Free University of Bruxelles, Brussels, Belgium Division of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Pubmed 27672107
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium, (DKTK), Berlin, Germany. · Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. · Department of Pathology, Center for Integrated Diagnostics (CID), Massachusetts General Hospital, Boston, MA, USA. · Hämatoonkologische Schwerpunktpraxis, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital Schleswig-Hostein, Kiel, Germany. · Praxisklinik Krebsheilkunde für Frauen/Brustzentrum, Berlin, Germany. · Department of Gynecology and Obstetrics, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institute of Pathology, Technical University Munich, Munich, Germany. · Center for Hematology and Oncology Bethanien, Frankfurt/Main, Germany. · Breast Unit, Kliniken Essen Mitte, Essen, Germany. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · German Breast Group c/o (GBG Forschungs GmbH), Neu-Isenburg, Germany. · Pubmed 27611952
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Lautenberg Centre, Hebrew University, Jerusalem, Israel. · Division of Medical Genetics, Department of Pediatrics and Neurobiology, Duke University, Durham, North Carolina. · Division of Cell Biology and Molecular Medicine, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia. · Pubmed 27231202
  • German Breast Group, Neu-Isenburg, Germany · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Surgery, Oncology and Gastroenterology, University of Padua, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · German Breast Group, Neu-Isenburg, Germany. · Frontier Science Scotland, Kincraig, UK. · Department of Medical Oncology, University of Verona, Verona, Italy. · Institute of Pathology, Charité Universitätsmedizin Berlin, and German Cancer Consortium (DKTK), Berlin. · Department of Obstetrics and Gynecology, University Hospital Kiel, Kiel, Germany. · Institut Jules Bordet, Université Libre de Bruxelles, Brussel, Belgium. · Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Obstetrics and Gynecology, Helios-Klinikum, Berlin-Buch, Germany. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 27177864
  • Department of Oncology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Pathology, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Department of Oncology, Regional Oncology Center, 66a Katowicka St, 45-060, Opole, Poland. · Department of Neurosurgery, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Medical University of Lublin, 1 Al. Racławickie, 20-059, Lublin, Poland. · Department of Oncology, Regional Oncology Center, 12 Ogrodowa St, 15-027, Białystok, Poland. · Department of Pathology, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Regional Hospital, 18 Żołnierska St, 10-561, Olsztyn, Poland. · Department of Oncology, Regional Oncology Center, 62 Pabianicka St, 93-513, Łódź, Poland. · Department of Pathology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, VIC, 8006, Australia. · Pubmed 27117582
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia · Pubmed 26487579
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 26255199
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia · Pubmed 25753442
2014
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne,Australia · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Service de Biostatistique et D'Epidemiology, Gustave Roussy, Universite Paris-Sud, Villejuif, France. · Department of Anatomical Pathology, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Tampere University Hospital, Tampere. · Department of Oncology, Helsinki University Central Hospital, Helsinki. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · German Breast Group, Neu-Isenburg. · Charité University Hospital, Institute of Pathology, Berlin, Germany. · Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute; School of Medicine, University of Queensland, Herston, Australia. · Pubmed 24608200
2013
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. · Pubmed 23776241
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
2010
  • Department of Research, Molecular Oncology Laboratory, Peter MacCallum Cancer Centre, East Melbourne 3002, Australia. · Pubmed 20479250
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2016
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United Kingdom; Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Michael F. Press, University of Southern California, Los Angeles, CA; and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
2015
  • From Royal Marsden Hospital, London (N.C.T.); National Cancer Center, Goyang-si, South Korea (J.R.); Institut Gustave Roussy, Villejuif, France (F.A.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi); Sunnybrook Odette Cancer Centre, Toronto (S.V.); Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany; Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.); and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology; Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain; Holger Eidtmann, University Hospital Kiel, Kiel; Nadia Harbeck, University of Munich, Munich, Germany; Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom; Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles; Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium; Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Catherine Ellis, GlaxoSmithKline, Collegeville, PA; and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin; Carsten Denkert, German Cancer Consortium (DKTK); Peter Klare, Praxisklinik and Breast Center; Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin; Micheal Untch, Helios Klinikum Berlin-Buch, Berlin; Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Women's Hospital, University of Frankfurt; Hans Tesch, Bethanien Hospital, Frankfurt; Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne; Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf; Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel; Christoph Salat, Onkologische Schwerpunktpraxis, Munich; Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz; Sherko Kümmel, Kliniken Essen-Mitte, Essen; Peter Sinn, University of Heidelberg, Heidelberg; Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach; Toralf Reimer, Klinikum Südstadt, Rostock, Germany; Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium; and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
2014
  • Translational Breast Cancer Genomics Laboratory, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25290412
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25188474
  • Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sibylle Loibl, Sana Klinikum, Offenbach; Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg; Gunter von Minckwitz, Universitäts-Frauenklinik; Fariba Khandan, Agaplesion Markus Krankenhaus; Clemens Heinrichs, OptiPath, Frankfurt; Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg; Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München; Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin; Michael Untch, Helios-Klinikum, Berlin; Mahdi Rezai, Luisenkrankenhaus; Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf; Dirk M. Zahm, SRH Waldklinikum, Gera; Holger Eidtmann, Universitäts-Frauenklinik, Kiel; Jens Huober, Universitäts-Frauenklinik, Ulm; Peter A. Fasching, Universitäts-Frauenklinik, Erlangen; August Dykgers, St Josef Hospital, Dortmund, Germany; Fabrice Andre, Institute Gustave Roussy, Villeueve, France; Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium; and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
2012
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 22820642
University of Melbourne